Markey John 13D and 13G filings for Vallon Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-27 11:09 am Sale | 2022-12-14 | 13G | Vallon Pharmaceuticals, Inc. VLON | Markey John | 0 0.000% | -28,316 (Position Closed) | Filing |
| 2022-09-28 5:47 pm Purchase | 2022-09-28 | 13G | Vallon Pharmaceuticals, Inc. VLON | Markey John | 28,316 8.100% | 28,316 (New Position) | Filing |